Four biguanidine derivatives with heterocyclic substituents, i.e., morpholine and 1-methylpiperazine, were prepared to investigate the impact of heterocyclic substituents on the geometry and antimicrobial activity of biguanidines. The chemical structure of the biguanidine salts was characterized by various spectroscopic techniques. Fortunately, the suitable crystals of two salts of C-[(4-methyl-piperazine-1-carboximidoyl)-amino]-C-(4-methyl-piperazin-1-yl)-methylene-ammonium chloride (1) and C-guanidino-C-morpholin-4-yl-methylene-ammonium chloride (4) were isolated to study the impact of monomorpholine and bis(1-methylpiperazine) substituent on biguanidine geometry. Biguanidine salt 1 crystallized in a monoclinic system with a space group of P21/n, and compound 4 was in an orthorhombic system with a space group of Pbca. The crystallography data revealed that the addition of one or two heterocyclic substituents causes no significant changes in bond length and angle in the biguanidine moiety; however, there was an increase in biguanidine torsion. Morpholine and 1-methylpiperazine rings exist in a chair conformation, and CN3 in guanidyl and NC3 in morpholine and 1-methylpiperazine rings, linked to guanidinyl moieties, imply a trigonal planar structure with a Csp2 and Nsp2 hybridization. The pharmacokinetics/ADMET properties and Lipinski's rule of five drug-likeness of biguanidine derivatives were predicted by the SwissADME. The ProToX-III prediction tool was employed for in silico toxicity evaluation. In-vitro cytotoxicity screening using HepG2 cells exhibited non-toxicity of biguanidine derivatives in the range of 3.125‒100 μg mL−1. Furthermore, the in vitro antibacterial activity of biguanidine derivatives and alexidine against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) was investigated using the broth microdilution method, which demonstrated high antibacterial activity of all derivatives with MIC values at a range of 7.81-250 μg mL−1. Alexidine bearing two biguanidine moieties linked by a hexamethylene carbon spacer exhibited the highest in vitro antibacterial activity against E. coli and S. aureus. Compound 1 exhibited more potent antibacterial activity with MICs of 7.81 μg mL−1 for E. coli and 31.25 μg mL−1 for S. aureus. The results revealed a slight impact of mono- and bis-heterocyclic substituents on the geometry and structural parameters; however, significant differences were observed in the pharmacokinetic properties, toxicity, and antibacterial activities of biguanidine derivatives.
扫码关注我们
求助内容:
应助结果提醒方式:
